Risk of immune-related colitis with PD-1/PD-L1 inhibitors vs chemotherapy in solid tumors: systems assessment

Background: We performed a meta-analysis to evaluate the risk of immune-related colitis associated with PD1/PD-L1 inhibitors as compared to chemotherapy in solid tumor patients. Methods: Eligible studies were identified through a comprehensive search of multiple databases and included solid tumor pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Qiang, Zhang, Xiaochen, Shen, Xinhua, Hou, Yanli, Sun, Zhigang, Gao, Zu Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950591/
https://www.ncbi.nlm.nih.gov/pubmed/29760800
http://dx.doi.org/10.7150/jca.24200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950591/
https://www.ncbi.nlm.nih.gov/pubmed/29760800
http://dx.doi.org/10.7150/jca.24200

Ejemplares similares